RCC
LJPC

Red Cedar Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Red Cedar Capital’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,500
Closed -$10K – 149
2019
Q4 		$10K Sell
2,500
-9,200
-79% -$54.3K 0.01% 112
2019
Q3 		$103K Hold
11,700
– – 0.08% 72
2019
Q2 		$108K Hold
11,700
– – 0.09% 74
2019
Q1 		$75K Buy
11,700
+5,000
+75% +$32.6K 0.06% 81
2018
Q4 		$63K Hold
6,700
– – 0.06% 84
2018
Q3 		$135K Buy
6,700
+1,000
+18% +$26.1K 0.12% 67
2018
Q2 		$166K Hold
5,700
– – 0.15% 66
2018
Q1 		$170K Buy
5,700
+1,000
+21% +$32.2K 0.15% 66
2017
Q4 		$151K Buy
+4,700
New +$154K 0.13% 68

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Red Cedar Capital's LJPC Position: Q1 2020 in Review

Red Cedar Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2020, closing a stake of 2,500 shares — an estimated $10K sold.

Red Cedar Capital first reported a position in LJPC in Q4 2017 and held it in 9 quarters. The position peaked at $170K in Q1 2018. 73 funds tracked by Wall St. Rank hold LJPC as of Q1 2020.

  • Red Cedar Capital reported no remaining La Jolla Pharmaceutical Company position as of Q1 2020 after selling out during the quarter.
  • Red Cedar Capital sold 2,500 La Jolla Pharmaceutical Company shares in Q1 2020, an estimated $10K.
  • Red Cedar Capital first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 9 quarters.
  • Red Cedar Capital's La Jolla Pharmaceutical Company position peaked at $170K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2020.

Based on Red Cedar Capital's 13F filing for Q1 2020, filed 30 Apr 2020.